Warrants Finder
Your selection:
266 Results
| FA87JY | Novartis AG/OS/Call [150]/SOC | - | - | 150.000 | call | Novartis AG | - | 22.972% | 0.128 | -0.010 | 14.492 | 12/18/2026 | 0.100 | Société Générale | ||
| FA87JZ | Novartis AG/OS/Call [150]/SOC | - | - | 150.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -4.610 | 06/18/2027 | 0.100 | Société Générale | ||
| FD6A01 | Novartis AG/OS/Call [150]/SOC | - | - | 150.000 | call | Novartis AG | - | 21.923% | 0.252 | -0.006 | 7.250 | 12/17/2027 | 0.100 | Société Générale | ||
| FE65XA | Novartis AG/OS/Call [150]/SOC | - | - | 150.000 | call | Novartis AG | - | 23.223% | 0.281 | -0.005 | 5.857 | 06/16/2028 | 0.100 | Société Générale | ||
| UN33QE |  | Novartis AG/OS/Call [150]/UniCredit | - | - | 150.000 | call | Novartis AG | - | 23.483% | 0.207 | -0.008 | 8.763 | 06/16/2027 | 0.100 | Unicredit | |
| UN4AT4 | | Novartis AG/OS/Call [150]/UniCredit | - | - | 150.000 | call | Novartis AG | - | 25.217% | 0.152 | -0.012 | 12.866 | 12/16/2026 | 0.100 | Unicredit | |
| UN6E6G | | Novartis AG/OS/Call [150]/UniCredit | - | - | 150.000 | call | Novartis AG | - | 25.240% | 0.181 | -0.009 | 9.822 | 03/17/2027 | 0.100 | Unicredit | |
| UR05LF | | Novartis AG/OS/Call [150]/UniCredit | - | - | 150.000 | call | Novartis AG | - | 22.361% | 0.257 | -0.007 | 7.095 | 12/15/2027 | 0.100 | Unicredit | |
| GW8HGF | Novartis AG/OS/Call [155]/GOLDS | - | - | 155.000 | call | Novartis AG | - | 26.495% | 0.157 | -0.009 | 9.671 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| UR0H85 | | Novartis AG/OS/Call [155]/UniCredit | - | - | 155.000 | call | Novartis AG | - | 25.418% | 0.144 | -0.008 | 10.275 | 03/17/2027 | 0.100 | Unicredit | |
| GU8N9R | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 41.988% | 0.088 | -0.021 | 13.734 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GU9N50 | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 29.132% | 0.114 | -0.011 | 11.893 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GW33RN | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 23.150% | 0.196 | -0.006 | 7.374 | 12/17/2027 | 0.100 | Goldman Sachs | ||
| GW33RX | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 24.852% | 0.152 | -0.007 | 8.929 | 06/18/2027 | 0.100 | Goldman Sachs | ||
| GW4DTQ | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 27.115% | 0.131 | -0.008 | 9.843 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW8STM | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 22.680% | 0.210 | -0.005 | 6.455 | 06/16/2028 | 0.100 | Goldman Sachs | ||
| GW97YP | Novartis AG/OS/Call [160]/GOLDS | - | - | 160.000 | call | Novartis AG | - | 51.442% | 0.062 | -0.025 | 16.357 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| MM8YXU | | Novartis AG/OS/Call [160]/MS | - | - | 160.000 | call | Novartis AG | - | - | - | - | - | 12/18/2026 | 0.100 | Morgan Stanley | |
| MM8YXV | | Novartis AG/OS/Call [160]/MS | - | - | 160.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -3.643 | 06/18/2027 | 0.100 | Morgan Stanley | |
| MM9WPA | | Novartis AG/OS/Call [160]/MS | - | - | 160.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -3.643 | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN25S6 | | Novartis AG/OS/Call [160]/MS | - | - | 160.000 | call | Novartis AG | - | - | - | - | - | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN6A27 | | Novartis AG/OS/Call [160]/MS | - | - | 160.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -3.643 | 03/19/2027 | 0.100 | Morgan Stanley | |
| MR333J | | Novartis AG/OS/Call [160]/MS | - | - | 160.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -3.643 | 06/16/2028 | 0.100 | Morgan Stanley | |
| FE03Y4 | Novartis AG/OS/Call [160]/SOC | - | - | 160.000 | call | Novartis AG | - | 31.623% | 0.033 | -0.007 | 21.066 | 09/18/2026 | 0.100 | Société Générale | ||
| FE03Y7 | Novartis AG/OS/Call [160]/SOC | - | - | 160.000 | call | Novartis AG | - | 24.296% | 0.101 | -0.006 | 11.433 | 03/19/2027 | 0.100 | Société Générale | ||
| FE03Y5 | Novartis AG/OS/Call [160]/SOC | - | - | 160.000 | call | Novartis AG | - | 24.879% | 0.075 | -0.007 | 14.919 | 12/18/2026 | 0.100 | Société Générale | ||
| FE65W9 | Novartis AG/OS/Call [160]/SOC | - | - | 160.000 | call | Novartis AG | - | 22.731% | 0.126 | -0.005 | 10.060 | 06/18/2027 | 0.100 | Société Générale | ||
| UN4L97 | | Novartis AG/OS/Call [160]/UniCredit | - | - | 160.000 | call | Novartis AG | - | 23.894% | 0.139 | -0.006 | 9.446 | 06/16/2027 | 0.100 | Unicredit | |
| UN4W97 | | Novartis AG/OS/Call [160]/UniCredit | - | - | 160.000 | call | Novartis AG | - | 27.006% | 0.093 | -0.009 | 13.372 | 12/16/2026 | 0.100 | Unicredit | |
| UN6SFX | | Novartis AG/OS/Call [160]/UniCredit | - | - | 160.000 | call | Novartis AG | - | 25.883% | 0.117 | -0.007 | 10.542 | 03/17/2027 | 0.100 | Unicredit | |
| UR05LG | | Novartis AG/OS/Call [160]/UniCredit | - | - | 160.000 | call | Novartis AG | - | 22.735% | 0.190 | -0.006 | 7.565 | 12/15/2027 | 0.100 | Unicredit | |
| GW8KH9 | Novartis AG/OS/Call [165]/GOLDS | - | - | 165.000 | call | Novartis AG | - | 26.266% | 0.095 | -0.006 | 10.758 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW5K88 | Novartis AG/OS/Call [170]/GOLDS | - | - | 170.000 | call | Novartis AG | - | 28.694% | 0.095 | -0.007 | 9.923 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW5K89 | Novartis AG/OS/Call [170]/GOLDS | - | - | 170.000 | call | Novartis AG | - | 32.061% | 0.085 | -0.010 | 11.510 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GW5K8M | Novartis AG/OS/Call [170]/GOLDS | - | - | 170.000 | call | Novartis AG | - | 26.175% | 0.114 | -0.006 | 9.035 | 06/18/2027 | 0.100 | Goldman Sachs | ||
| GW5N7A | Novartis AG/OS/Call [170]/GOLDS | - | - | 170.000 | call | Novartis AG | - | 23.689% | 0.148 | -0.005 | 7.704 | 12/17/2027 | 0.100 | Goldman Sachs | ||
| GW92MP | Novartis AG/OS/Call [170]/GOLDS | - | - | 170.000 | call | Novartis AG | - | 44.470% | 0.054 | -0.015 | 14.134 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| UR05LH | | Novartis AG/OS/Call [170]/UniCredit | - | - | 170.000 | call | Novartis AG | - | 23.182% | 0.141 | -0.005 | 7.948 | 12/15/2027 | 0.100 | Unicredit | |
| GU9H4W | Novartis AG/OS/Call [180]/GOLDS | - | - | 180.000 | call | Novartis AG | - | 55.530% | 0.067 | -0.022 | 11.123 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GW33RP | Novartis AG/OS/Call [180]/GOLDS | - | - | 180.000 | call | Novartis AG | - | 35.930% | 0.074 | -0.010 | 10.626 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GW33RR | Novartis AG/OS/Call [180]/GOLDS | - | - | 180.000 | call | Novartis AG | - | 24.533% | 0.116 | -0.005 | 7.843 | 12/17/2027 | 0.100 | Goldman Sachs | ||
| GW33TS | Novartis AG/OS/Call [180]/GOLDS | - | - | 180.000 | call | Novartis AG | - | 27.444% | 0.087 | -0.005 | 9.078 | 06/18/2027 | 0.100 | Goldman Sachs | ||
| GW4DTX | Novartis AG/OS/Call [180]/GOLDS | - | - | 180.000 | call | Novartis AG | - | 31.011% | 0.078 | -0.006 | 9.572 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW8STH | Novartis AG/OS/Call [180]/GOLDS | - | - | 180.000 | call | Novartis AG | - | 23.201% | 0.125 | -0.004 | 7.059 | 06/16/2028 | 0.100 | Goldman Sachs | ||
| MN3L0H | | Novartis AG/OS/Call [180]/MS | - | - | 180.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -2.305 | 06/18/2027 | 0.100 | Morgan Stanley | |
| MN3L0J | | Novartis AG/OS/Call [180]/MS | - | - | 180.000 | call | Novartis AG | - | - | - | - | - | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN3L0K | | Novartis AG/OS/Call [180]/MS | - | - | 180.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -2.305 | 12/17/2027 | 0.100 | Morgan Stanley | |
| MN7M4R | | Novartis AG/OS/Call [180]/MS | - | - | 180.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -2.163 | 03/19/2027 | 0.100 | Morgan Stanley | |
| MR333K | | Novartis AG/OS/Call [180]/MS | - | - | 180.000 | call | Novartis AG | - | - | 1.000 | 0.000 | -2.305 | 06/16/2028 | 0.100 | Morgan Stanley | |
| GW5KA1 | Novartis AG/OS/Call [190]/GOLDS | - | - | 190.000 | call | Novartis AG | - | 33.356% | 0.067 | -0.006 | 9.186 | 03/19/2027 | 0.100 | Goldman Sachs |